Atara Biotherapeutics, Inc. (ATRA) vs Cardiff Oncology, Inc. (CRDF)
A side-by-side comparison of Atara Biotherapeutics, Inc. and Cardiff Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATRA
Atara Biotherapeutics, Inc.
$9.35HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
CRDF
Cardiff Oncology, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 2:56 PM EDT
Total return — ATRA vs CRDF
growth of $100 · dividends reinvested · last 10yATRA -98.0% (-32.3%/yr)CRDF -99.6% (-43.1%/yr)ATRA compounded faster over this window
Log scale — wide-divergence pair
ATRA CRDF
ATRA vs CRDF: by the numbers
- •ATRA is the larger company ($84M vs $84M market cap).
- •Both run net losses; ATRA's is the smaller (-269.42% vs -7884.06% net margin).
- •ATRA grew revenue faster over the past five years (56.10% vs 5.15% CAGR).
Metrics side by side
Valuation
| Metric | ATRA | CRDF |
|---|---|---|
| P/S ratio | 13.60 | 164.62 |
| P/B ratio | N/A | 3.15 |
Profitability
| Metric | ATRA | CRDF |
|---|---|---|
| Gross margin | 82.44% | 100.00% |
| Operating margin | 29.69% | -8256.32% |
| Net margin | -269.42% | -7884.06% |
| ROE | N/A | -150.95% |
| ROIC | -100.35% | -159.30% |
Growth (annualized)
| Metric | ATRA | CRDF |
|---|---|---|
| Revenue CAGR (5Y) | 56.10% | 5.15% |
| Total return CAGR (5Y) | -53.60% | -30.36% |
Frequently asked
- Which has grown faster, ATRA or CRDF?
- Over the past five years, ATRA grew revenue faster — ATRA at a 56.10% CAGR versus CRDF at 5.15%.
- How have ATRA and CRDF total returns compared?
- Over the past 10 years, ATRA delivered -32.27% and CRDF delivered -43.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Atara Biotherapeutics ROECardiff Oncology ROEAtara Biotherapeutics operating marginCardiff Oncology operating marginAtara Biotherapeutics revenue growthCardiff Oncology revenue growthAtara Biotherapeutics free cash flowCardiff Oncology free cash flow
Atara Biotherapeutics & Cardiff Oncology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.